Target Cancer

 
News Articles for Target Cancer top ^
Verastem, Inc. (NASDAQ:VSTM), focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today announced publication of an article titled “FAK Inhibitor Kills Mesothelioma Cells” in Cancer Discovery , a medical journal published by the American Association for Cancer Research (AACR). The commentary references preclinical scientific data on targeting mesothelioma cancer stem cells through inhibition of focal adhesion kinase (FAK) that was recently published in Science Translational Medicine (Vol. 6, Issue 237, p.237ra68). Two of Verastem’s lead drug candidates, VS-6063 and VS-4718, target cancer stem cells through potent inhibition of FAK.
Sign-up for The Potential of Targeting Cancer Stem Cells Through FAK Inhibition in Mesothelioma Reported in AACR’s Cancer Discovery investment picks
Seven presentations at the 2014 American Association of Physicists in Medicine (AAPM) meeting to focus on early adopters' work with Varian's Edge radiosurgery system AUSTIN, Texas , July 17, 2014 /PRNewswire/ -- Medical researchers have confirmed that the Edge™ radiosurgery system from Varian Medical Systems (NYSE:VAR) can deliver dose to a targeted tumor with sub-millimeter isocenter accuracy.
Sign-up for Researchers Show that the Edge™ Radiosurgery System from Varian Medical Systems Can Target Cancer with Sub-millimeter Accuracy investment picks

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Target Cancer
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Target Bond Funds  |  Next: Target Companies